Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...

Полное описание

Библиографические подробности
Главные авторы: Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Формат: Journal article
Язык:English
Опубликовано: 2012

Схожие документы